A5109138376- Climate Change and Health Impacts
- Birth, Development, and Health
- Cancer Treatment and Pharmacology
- Vaccine Coverage and Hesitancy
- Breast Cancer Treatment Studies
- Medical Coding and Health Information
- COVID-19 epidemiological studies
- SARS-CoV-2 and COVID-19 Research
- Global Maternal and Child Health
- HER2/EGFR in Cancer Research
- Maternal and fetal healthcare
- Healthcare Systems and Reforms
- Pregnancy and preeclampsia studies
Alexandria University
2004-2012
Abstract Objectives To evaluate the performance of mean arterial pressure, uterine artery pulsatility index and soluble endoglin level alone or in combination screening for hypertensive disorders pregnant women without a‐priori high risk. Methods This was a nested case–control study with singleton pregnancies risk who developed pregnancy‐induced complications. Women were enrolled into at 11–14 weeks' gestation, when pressure recorded blood sample taken measurement endoglin. followed up...
Abstract Background More than 50% of breast cancers are currently defined as “Human epidermal growth factor receptor 2 (HER2) low cancer (BC)”. Nevertheless, little is known about the response and prognosis HER2-low BC receiving neoadjuvant chemotherapy (NACT). Aim Work The purpose our study to evaluate impact HER2status (HER2 vs zero) on (NACT) in HER2− BC. Patients Methods This a retrospective that included 96 patients attending clinic at Clinical Oncology Department, Ain Shams University...